Mats Talbäck
- Oncology top 2%
- Global Cancer Incidence and Screening 16
- Cancer Risks and Factors 8
- Colorectal Cancer Screening and Detection 8
- Hepatology top 5%
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 7
-
- Childhood Cancer Survivors' Quality of Life 16
-
- Acute Lymphoblastic Leukemia research 9
-
- Adolescent and Pediatric Healthcare 8
-
- Family Support in Illness 8
In The Last Decade
Mats Talbäck
82 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 1.5k
- Hepatology 282
- Endocrinology, Diabetes and Metabolism 528
- Epidemiology 946
- Medical Laboratory Technology 35
Countries citing papers authored by Mats Talbäck
This map shows the geographic impact of Mats Talbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Talbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Talbäck more than expected).
Fields of papers citing papers by Mats Talbäck
This network shows the impact of papers produced by Mats Talbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Talbäck. The network helps show where Mats Talbäck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mats Talbäck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 34 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 122 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 8 | |
| 17 | 2011 | 30 | |
| 18 | Rapportering till Cancerregistret kan förbättras | 2009 | 0 |
| 19 | 2005 | 22 | |
| 20 | [Incidence and mortality of breast cancer during a 25-year period. International and regional comparisons]. | 2000 | 6 |
About Mats Talbäck
Mats Talbäck is a scholar working on Speech and Hearing, Oncology, Pediatrics, Perinatology and Child Health, Medical Laboratory Technology and Health, having authored 85 papers that have together received 4.6k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (16 papers), Global Cancer Incidence and Screening (16 papers), Acute Lymphoblastic Leukemia research (9 papers), Cancer Risks and Factors (8 papers), Adolescent and Pediatric Healthcare (8 papers), Colorectal Cancer Screening and Detection (8 papers), Family Support in Illness (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (1.5k citations), Hepatology (282 citations), Endocrinology, Diabetes and Metabolism (528 citations), Epidemiology (946 citations) and Medical Laboratory Technology (35 citations). Mats Talbäck has collaborated with scholars based in Sweden, Denmark and Finland. Frequent co-authors include Lotti Barlow, Lars Holmberg, Rickard Ljung, Maria Feychting, Hannah L. Brooke, Lars Johansson, Jonas F. Ludvigsson, Henrik Druid, Bjørn Møller and Harald Weedon‐Fekjær. Their work appears in journals such as Acta Oncologica, Cancer Medicine, Cancer, European Journal of Cancer and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.